Pradipta Bhakta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pradipta Bhakta has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
- Habib Md Reazaul Karim
Anaesthesiology, Critical Care & Pain Medicine, All India Institute of Medical Sciences Guwahati, Guwahati, Assam, India
28 shared publications - Antonio Matias Esquinas
Intensive Care Unit, Hospital Morales Meseguer, 30008 Murcia, Spain
14 shared publications Brian O’bRien
Department of Anesthesia and Intensive Care, Cork University Hospital, Cork, Ireland
11 shared publicationsBrian O'BRien
Department of Anesthesiology and Intensive Care, Cork University Hospital, Cork, Ireland
8 shared publicationsMohanchandra Mandal
Department of Anesthesiology and Intensive Care, Institute of Postgraduate Medical Education and Research, Kolkata, India
7 shared publications- Brian O'Brien
Department of Anaesthesiology and Intensive Care, Cork University Hospital, Cork, Ireland
6 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-2
Implementation of Acupuncture Treatment in the Modern Operating Environment: Our Reply to Study by Zou X et al [Letter]
Letter for the article Cheek Acupuncture Reduces Postoperative Sore Throat After Double-Lumen Endobronchial Intubation: A Randomized Controlled Trial
- 1 July 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-2
Open AccessImplementation of Acupuncture Treatment in the Modern Operating Environment: Our Reply to Study by Zou X et al [Letter]
Letter for the article Cheek Acupuncture Reduces Postoperative Sore Throat After Double-Lumen Endobronchial Intubation: A Randomized Controlled Trial
- 14 January 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 142 (2) , 418-419
Remifentanil and Dexmedetomidine Treat Hypertension: Comment
- 14 January 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 142 (2) , 418-419
Remifentanil and Dexmedetomidine Treat Hypertension: Comment
- 20 June 2024
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 71 (8) , 1179-1180
Comparing approaches to the difficult airway
- 20 June 2024
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 71 (8) , 1179-1180
Comparing approaches to the difficult airway
- 13 June 2024
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 139 (4) , e31-e32
Anesthesiologists’ Choices and Their Teleologic Consequences
- 13 June 2024
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 139 (4) , e31-e32
Anesthesiologists’ Choices and Their Teleologic Consequences
- 26 November 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 210-211
Effect of a pre-emptive 2-hour session of high-flow nasal oxygen on postoperative oxygenation after major gynaecologic surgery. Comment on Br J Anaesth 2023; 131: 775–85
- 26 November 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (1) , 210-211
Effect of a pre-emptive 2-hour session of high-flow nasal oxygen on postoperative oxygenation after major gynaecologic surgery. Comment on Br J Anaesth 2023; 131: 775–85
- 2 November 2023
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 71 (1) , 154-155
Comparing devices for managing the difficult airway
- 2 November 2023
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 71 (1) , 154-155
Comparing devices for managing the difficult airway
- 1 January 2023
- Published by Springer Nature
- p. 359-380
Pharmacological Therapy for the Management of Patient Ventilator Asynchrony During Noninvasive Ventilation
- 1 January 2023
- Published by Springer Nature
- p. 359-380
Pharmacological Therapy for the Management of Patient Ventilator Asynchrony During Noninvasive Ventilation
- 26 October 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 73, 154177
Letter to the editor: “Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19---insights from the PRoVENT-COVID study”
- 26 October 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 73, 154177
Letter to the editor: “Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID-19---insights from the PRoVENT-COVID study”
- Open Access
- 30 July 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (8) , 938-948
Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations
This systematic review aimed to investigate the drugs used and their potential effect on noninvasive ventilation (NIV). NIV is used increasingly in acute respiratory failure (ARF). Sedation and analgesia are potentially beneficial in NIV, but they can have a deleterious impact. Proper guidelines to specifically address this issue and the recommendations for or against it are scarce in the literature. In the most recent guidelines published in 2017 by the European Respiratory Society/American Thoracic Society (ERS/ATS) relating to NIV use in patients having ARF, the well-defined recommendation on the selective use of sedation and analgesia is missing. Nevertheless, some national guidelines suggested using sedation for agitation. Electronic databases (PubMed/Medline, Google Scholar, and Cochrane library) from January 1999 to December 2019 were searched systematically for research articles related to sedation and analgosedation in NIV. A brief review of the existing literature related to sedation and analgesia was also done. Sixteen articles (five randomized trials) were analyzed. Other trials, guidelines, and reviews published over the last two decades were also discussed. The present review analysis suggests dexmedetomidine as the emerging sedative agent of choice based on the most recent trials because of better efficacy with an improved and predictable cardiorespiratory profile. Current evidence suggests that sedation has a potentially beneficial role in patients at risk of NIV failure due to interface intolerance, anxiety, and pain. However, more randomized controlled trials are needed to comment on this issue and formulate strong evidence-based recommendations. Karim HMR, Šarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, et al. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian J Crit Care Med 2022;26(8):938–948.
- 30 July 2022
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 26 (8) , 938-948
Open AccessRole of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations
This systematic review aimed to investigate the drugs used and their potential effect on noninvasive ventilation (NIV). NIV is used increasingly in acute respiratory failure (ARF). Sedation and analgesia are potentially beneficial in NIV, but they can have a deleterious impact. Proper guidelines to specifically address this issue and the recommendations for or against it are scarce in the literature. In the most recent guidelines published in 2017 by the European Respiratory Society/American Thoracic Society (ERS/ATS) relating to NIV use in patients having ARF, the well-defined recommendation on the selective use of sedation and analgesia is missing. Nevertheless, some national guidelines suggested using sedation for agitation. Electronic databases (PubMed/Medline, Google Scholar, and Cochrane library) from January 1999 to December 2019 were searched systematically for research articles related to sedation and analgosedation in NIV. A brief review of the existing literature related to sedation and analgesia was also done. Sixteen articles (five randomized trials) were analyzed. Other trials, guidelines, and reviews published over the last two decades were also discussed. The present review analysis suggests dexmedetomidine as the emerging sedative agent of choice based on the most recent trials because of better efficacy with an improved and predictable cardiorespiratory profile. Current evidence suggests that sedation has a potentially beneficial role in patients at risk of NIV failure due to interface intolerance, anxiety, and pain. However, more randomized controlled trials are needed to comment on this issue and formulate strong evidence-based recommendations. Karim HMR, Šarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, et al. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian J Crit Care Med 2022;26(8):938–948.
- Open Access
- 28 July 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (4) , 279-280
Intelligent Volume-Assured Pressure Support vs. Spontaneous/Timed Mode as a Weaning Strategy in COPD—Evaluation of a New Ventilation Strategy
- 28 July 2022
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 90 (4) , 279-280
Open AccessIntelligent Volume-Assured Pressure Support vs. Spontaneous/Timed Mode as a Weaning Strategy in COPD—Evaluation of a New Ventilation Strategy